Cargando…
Recent advances in the treatment of pancreatic cancer
Pancreatic ductal adenocarcinoma is one of the deadliest solid tumor malignancies and is projected to become a leading cause of cancer-related death in coming years. Improving quality of life and survival amongst these patients will require new ideas and novel therapies in a multidisciplinary approa...
Autores principales: | Roth, Marc T, Cardin, Dana B, Berlin, Jordan D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043109/ https://www.ncbi.nlm.nih.gov/pubmed/32148767 http://dx.doi.org/10.12688/f1000research.21981.1 |
Ejemplares similares
-
Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer
por: LaPelusa, Michael, et al.
Publicado: (2022) -
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
por: Cardin, Dana B, et al.
Publicado: (2014) -
Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer
por: Nedelcu, Andreea, et al.
Publicado: (2021) -
Recent advances in understanding pancreatic cancer
por: Stott, Martyn C, et al.
Publicado: (2022) -
Recent advances in radiation therapy of pancreatic cancer
por: Venkatesulu, Bhanu Prasad, et al.
Publicado: (2018)